Search - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Access content directly

Filter your results

4 Results
authFullName_s : Eric Frampas

Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma.

Pierre-Yves Salaun , Caroline Bodet-Milin , Eric Frampas , Aurore Oudoux , Catherine Saï-Maurel , et al.
Cancer, 2010, 116 (4 Suppl), pp.1053-8. ⟨10.1002/cncr.24792⟩
Journal articles hal-00930166v1
Image document

Tumor Immunotargeting Using Innovative Radionuclides

Françoise Kraeber-Bodéré , Caroline Rousseau , Caroline Bodet-Milin , Cédric Mathieu , François Guérard , et al.
International Journal of Molecular Sciences, 2015, 16 (2), pp.3932 - 3954. ⟨10.3390/ijms16023932⟩
Journal articles inserm-01818715v1

¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.

Pierre-Yves Salaun , Loïc Campion , Catherine Ansquer , Eric Frampas , Cédric Mathieu , et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 (8), pp.1501-1510
Journal articles hal-01111285v1
Image document

A pretargeting system for tumor PET imaging and radioimmunotherapy

Françoise Kraeber-Bodéré , Caroline Rousseau , Caroline Bodet-Milin , Eric Frampas , Alain Faivre-Chauvet , et al.
Frontiers in Pharmacology, 2015, 6, pp.54. ⟨10.3389/fphar.2015.00054⟩
Journal articles inserm-02913677v1